Profile | GDS4284 / 237563_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 363.532 | 59 |
GSM687648 | Patient 402 control | 423.278 | 61 |
GSM687653 | Patient 403 control | 202.312 | 50 |
GSM687658 | Patient 404 control | 554.535 | 65 |
GSM687663 | Patient 411 control | 515.748 | 64 |
GSM687668 | Patient 422 control | 449.763 | 62 |
GSM687673 | Patient 424 control | 528.902 | 64 |
GSM687678 | Patient 425 control | 561.791 | 64 |
GSM687683 | Patient 427 control | 392.681 | 58 |
GSM687688 | Patient 428 control | 348.378 | 58 |
GSM687695 | Patient 441 control | 1751.29 | 83 |
GSM687699 | Patient 443 control | 548.496 | 64 |
GSM687704 | Patient 444 control | 410.105 | 61 |
GSM687707 | Patient 448 control | 394.566 | 59 |
GSM687712 | Patient 449 control | 475.308 | 63 |
GSM687719 | Patient 450 control | 825.982 | 71 |
GSM687724 | Patient 451 control | 73.0809 | 26 |
GSM687728 | Patient 452 control | 501.315 | 64 |
GSM687646 | Patient 401 treated 24h | 420.489 | 60 |
GSM687649 | Patient 402 treated 24h | 326.539 | 57 |
GSM687665 | Patient 411 treated 24h | 475.708 | 62 |
GSM687651 | Patient 402 treated 4 weeks | 480.175 | 62 |
GSM687667 | Patient 411 treated 4 weeks | 457.556 | 62 |
GSM687670 | Patient 422 treated 24h | 628.887 | 66 |
GSM687671 | Patient 422 treated 4 weeks | 631.811 | 67 |
GSM687654 | Patient 403 treated 24h | 461.414 | 63 |
GSM687675 | Patient 424 treated 24h | 774.592 | 70 |
GSM687685 | Patient 427 treated 24h | 540.984 | 64 |
GSM687656 | Patient 403 treated 4 weeks | 504.714 | 64 |
GSM687677 | Patient 424 treated 4 weeks | 684.748 | 68 |
GSM687687 | Patient 427 treated 4 weeks | 278.356 | 55 |
GSM687692 | Patient 428 treated 4h | 415.204 | 61 |
GSM687716 | Patient 449 treated 4h | 240.291 | 53 |
GSM687722 | Patient 450 treated 4h | 597.12 | 65 |
GSM687680 | Patient 425 treated 24h | 437.05 | 61 |
GSM687690 | Patient 428 treated 24h | 395.466 | 61 |
GSM687700 | Patient 443 treated 24h | 963.201 | 73 |
GSM687705 | Patient 444 treated 24h | 762.366 | 70 |
GSM687714 | Patient 449 treated 24h | 535.698 | 65 |
GSM687721 | Patient 450 treated 24h | 1221.44 | 77 |
GSM687682 | Patient 425 treated 4 weeks | 402.12 | 61 |
GSM687694 | Patient 428 treated 4 weeks | 246.331 | 53 |
GSM687702 | Patient 443 treated 4 weeks | 483.204 | 62 |
GSM687718 | Patient 449 treated 4 weeks | 320.398 | 57 |
GSM687723 | Patient 450 treated 4 weeks | 549.936 | 65 |
GSM687661 | Patient 404 treated 4h | 593.835 | 66 |
GSM687710 | Patient 448 treated 4h | 516.998 | 65 |
GSM687726 | Patient 451 treated 4h | 368.654 | 58 |
GSM687730 | Patient 452 treated 4h | 1996.31 | 85 |
GSM687660 | Patient 404 treated 24h | 2909.85 | 89 |
GSM687697 | Patient 441 treated 24h | 1505.16 | 81 |
GSM687709 | Patient 448 treated 24h | 389.082 | 59 |
GSM687725 | Patient 451 treated 24h | 565.277 | 65 |
GSM687729 | Patient 452 treated 24h | 2005.06 | 85 |
GSM687727 | Patient 451 treated 4 weeks | 338.967 | 56 |
GSM687731 | Patient 452 treated 4 weeks | 823.401 | 71 |